You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Harvard Business School
Mallinckrodt
Johnson and Johnson
AstraZeneca

Last Updated: February 18, 2020

DrugPatentWatch Database Preview

Litigation Details for Telcordia Tech Inc. v. Lucent Technologies (D. Del. 2004)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Telcordia Tech Inc. v. Lucent Technologies (D. Del. 2004)

Docket   Start Trial Date Filed 2004-07-16
Court District Court, D. Delaware Date Terminated 2007-05-04
Cause 28:1338 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand Both Referred To
Parties LUCENT TECHNOLOGIES, INC.; TELCORDIA TECHNOLOGIES INC.
Patents 4,957,745; 6,008,228; 7,078,020; 9,109,010
Attorneys David A. Nelson; Geoffrey Mason; Israel S. Mayergoyz; John G. Day; John M. Williamson; John W. Shaw; Neilesh R. Patel; Steven J. Balick; Tiffany Geyer Lydon
Link to Docket External link to docket
Small Molecule Drugs cited in Telcordia Tech Inc. v. Lucent Technologies
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Telcordia Tech Inc. v. Lucent Technologies
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for Telcordia Tech Inc. v. Lucent Technologies (D. Del. 2004)

Date Filed Document No. Description Snippet Link To Document
2007-03-02 317 Exhibit 4-5 ;s:827: External link to document
2007-03-09 334 Exhibit D1 through H responsive 215:14 – 20 602 216:6 – 8 228:16 – 229:2 229:13 – 230:11 230:16 – 231:7 232:…infringement of the ’763 patent and regarding the validity and enforceability of the ’763 patent, should Cisco …Advanced Patent Law Institute “Where are the Costs in Patent Litigation…invalidity of the ’306 and ’633 patents, and the non-infringement of the ’633 patent. In addition…area of patent licensing, specifically license agreements related to telecommunications patents. His work External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Colorcon
Mallinckrodt
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.